184 related articles for article (PubMed ID: 9657528)
1. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
[TBL] [Abstract][Full Text] [Related]
2. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
3. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
4. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.
Heyes MP; Mefford IN; Quearry BJ; Dedhia M; Lackner A
Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238
[TBL] [Abstract][Full Text] [Related]
5. Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid.
Heyes MP; Jordan EK; Lee K; Saito K; Frank JA; Snoy PJ; Markey SP; Gravell M
Brain Res; 1992 Jan; 570(1-2):237-50. PubMed ID: 1535532
[TBL] [Abstract][Full Text] [Related]
6. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
7. Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D.
Heyes MP; Gravell M; London WT; Eckhaus M; Vickers JH; Yergey JA; April M; Blackmore D; Markey SP
Brain Res; 1990 Oct; 531(1-2):148-58. PubMed ID: 1963097
[TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART.
Drewes JL; Meulendyke KA; Liao Z; Witwer KW; Gama L; Ubaida-Mohien C; Li M; Notarangelo FM; Tarwater PM; Schwarcz R; Graham DR; Zink MC
J Neurovirol; 2015 Aug; 21(4):449-63. PubMed ID: 25776527
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain.
Heyes MP; Saito K; Jacobowitz D; Markey SP; Takikawa O; Vickers JH
FASEB J; 1992 Aug; 6(11):2977-89. PubMed ID: 1322853
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.
Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Tattam B; Brew BJ
Neurology; 1997 Dec; 49(6):1671-81. PubMed ID: 9409365
[TBL] [Abstract][Full Text] [Related]
12. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
13. Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques.
Saito K; Lackner A; Markey SP; Heyes MP
Brain Res; 1991 Feb; 540(1-2):353-6. PubMed ID: 1647247
[TBL] [Abstract][Full Text] [Related]
14. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
Smith MO; Heyes MP; Lackner AA
Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
[TBL] [Abstract][Full Text] [Related]
15. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.
Heyes MP; Ellis RJ; Ryan L; Childers ME; Grant I; Wolfson T; Archibald S; Jernigan TL;
Brain; 2001 May; 124(Pt 5):1033-42. PubMed ID: 11335705
[TBL] [Abstract][Full Text] [Related]
16. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
17. Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia.
Heyes MP; Lackner A
J Neurochem; 1990 Jul; 55(1):338-41. PubMed ID: 2141357
[TBL] [Abstract][Full Text] [Related]
18. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
Saito K; Crowley JS; Markey SP; Heyes MP
J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
20. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response.
Brouwers P; Heyes MP; Moss HA; Wolters PL; Poplack DG; Markey SP; Pizzo PA
J Infect Dis; 1993 Dec; 168(6):1380-6. PubMed ID: 8245522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
